BioPharmX Corp. | Balance Sheet

Fiscal year is February-January. All values USD Thousands.
2013
2014
2016
2017
2018
2019
Cash & Short Term Investments
0.20
2,111.00
4,039.00
6,501.00
7,576.00
3,069
Total Accounts Receivable
-
2.00
7.00
4.00
7.00
4
Inventories
-
138.00
100.00
38.00
10.00
-
Other Current Assets
-
269.00
285.00
284.00
388.00
312
Total Current Assets
0.20
2,520.00
4,431.00
6,827.00
7,981.00
3,385
Net Property, Plant & Equipment
-
235.00
216.00
120.00
109.00
148
Total Investments and Advances
-
35.00
35.00
-
-
-
Intangible Assets
-
150.00
119.00
-
-
-
Other Assets
-
50.00
50.00
154.00
-
121
Total Assets
0.20
2,990.00
4,851.00
7,101.00
8,090.00
3,654
Accounts Payable
-
-
1,777.00
2,551.00
1,376.00
Other Current Liabilities
120.10
1,367.00
1,020.00
1,176.00
1,603.00
Total Current Liabilities
120.10
1,367.00
2,797.00
3,727.00
2,979.00
Long-Term Debt
2.90
-
-
-
-
Other Liabilities
-
-
-
403.00
39.00
Total Liabilities
123.10
1,367.00
2,797.00
4,130.00
3,018.00
Common Equity (Total)
122.90
5,107.00
2,054.00
1,456.00
5,072.00
Total Shareholders' Equity
122.90
1,623.00
2,054.00
2,971.00
5,072.00
Total Equity
122.90
1,623.00
2,054.00
2,971.00
5,072.00
Liabilities & Shareholders' Equity
0.20
2,990.00
4,851.00
7,101.00
8,090.00
Preferred Stock (Carrying Value)
-
6,730.00
-
1,515.00
-

About BioPharmX

View Profile
Address
115 Nicholson Lane
San Jose California 95134
United States
Employees -
Website http://www.biopharmx.com
Updated 07/08/2019
BioPharmX Corp. engages in the provision of healthcare products through platform technologies for pharmaceutical, over-the-counter, and supplement applications in dermatology. Its platforms include Topical Gel, Injectable, and Encapsulation. The company was founded by James R.